![]() |
Tepotinib
- 英文名称:Tepotinib
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11538
- cas:1100598-32-0
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-04-30
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11538 |
用途 | 科研检测 |
英文名称 | Tepotinib |
包装规格 | 1MG |
CAS编号 | 1100598-32-0 |
别名 | Tepotinib |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:>98% by TLC;NMR (Conforms)
分子式:C29H28N6O2
分子量:492.58
溶剂:DMSO (17 mg/ml with warming)
性状:White solid
存储:-20°C
Activity (short version):c-Met inhibitor
Function / Pharmacology:Tepotinib is a selective type 1b MET inhibitor. In biochemical assays using His6-tagged recombinant human MET kinase domain, tepotinib inhibited kinase activity in a concentration-dependent manner with IC50=1.8 nM.1 It displays marked antitumor activity in MET-dependent tumor models.2 It crosses the blood-brain barrier and displays intracranial antitumor activity.3 Tepotinib can overcome EGFR inhibitor resistance mediated by aberrant c-Met activation4 and is in clinical use for non-small cell lung cancer harboring MET exon 14 skipping alterations.
分子式:C29H28N6O2
分子量:492.58
溶剂:DMSO (17 mg/ml with warming)
性状:White solid
存储:-20°C
Activity (short version):c-Met inhibitor
Function / Pharmacology:Tepotinib is a selective type 1b MET inhibitor. In biochemical assays using His6-tagged recombinant human MET kinase domain, tepotinib inhibited kinase activity in a concentration-dependent manner with IC50=1.8 nM.1 It displays marked antitumor activity in MET-dependent tumor models.2 It crosses the blood-brain barrier and displays intracranial antitumor activity.3 Tepotinib can overcome EGFR inhibitor resistance mediated by aberrant c-Met activation4 and is in clinical use for non-small cell lung cancer harboring MET exon 14 skipping alterations.